Showing 1 - 9 results of 9 for search 'LiuLu Zhang', query time: 0.08s
Refine Results
-
1
-
2
Adjuvant CDK4/6 inhibitors combined with endocrine therapy in HR-positive, HER2-negative early breast cancer: A meta-analysis of randomized clinical trials by Hong-Fei Gao, Ying-Yi Lin, Teng Zhu, Fei Ji, Liu-Lu Zhang, Ci-Qiu Yang, Mei Yang, Jie-Qing Li, Min-Yi Cheng, Kun Wang
Published 2021-10-01
Article -
3
-
4
-
5
-
6
Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic and Neoadjuvant Chemotherapy Relevant Signatures by Fei Ji, Jiao-Mei Yuan, Hong-Fei Gao, Ai-Qi Xu, Zheng Yang, Ci-Qiu Yang, Liu-Lu Zhang, Mei Yang, Jie-Qing Li, Teng Zhu, Min-Yi Cheng, Si-Yan Wu, Kun Wang
Published 2021-10-01
Article -
7
Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective studyResearch... by YuHong Huang, Teng Zhu, XiaoLing Zhang, Wei Li, XingXing Zheng, MinYi Cheng, Fei Ji, LiuLu Zhang, CiQiu Yang, ZhiYong Wu, GuoLin Ye, Ying Lin, Kun Wang
Published 2023-04-01
Article -
8
Peritoneal Metastasis After Treated With Abemaciclib Plus Fulvestrant for Metastatic Invasive Lobular Breast Cancer: A Case Report and Review of the Literature by Hong-Fei Gao, Jun-Sheng Zhang, Jun-Sheng Zhang, Qiang-Zu Zhang, Teng Zhu, Ci-Qiu Yang, Liu-Lu Zhang, Mei Yang, Fei Ji, Jie-Qing Li, Min-Yi Cheng, Gang Niu, Kun Wang, Kun Wang
Published 2021-10-01
Article -
9
Anthracycline-containing carboplatin-containing neoadjuvant chemotherapy in combination with trastuzumab for HER2-positive breast cancer: the neoCARH phase II randomized clinical... by Hong-Fei Gao, Zhiyong Wu, Ying Lin, Xiang-Yang Song, Yin Cao, Qian-Jun Chen, Gangling Zhang, Peifen Fu, Zhenzhen Liu, Liu-Lu Zhang, Ci-Qiu Yang, Mei Yang, Teng Zhu, Fei Ji, Jie-Qing Li, Min-Yi Cheng, Kun Wang
Published 2021-04-01
Article